Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy
Abstract Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical picture of MMN patients, ameliorating motor symptoms and/o...
Guardado en:
Autores principales: | Luca Gentile, Massimo Russo, Carmelo Rodolico, Ilenia Arimatea, Giuseppe Vita, Antonio Toscano, Anna Mazzeo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/949207f73311409782fe52dc677986fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
por: Kobrynski L
Publicado: (2012) -
Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
por: S Shahzad Mustafa, et al.
Publicado: (2021) -
Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use
por: Ivan Pasic, et al.
Publicado: (2021) -
Multifocal stimulation of the cerebro-cerebellar loop during the acquisition of a novel motor skill
por: Maximilian J. Wessel, et al.
Publicado: (2021) -
Long‐term remission of severe livedoid vasculopathy treated with a short course of intravenous immunoglobulin
por: Shunsuke Takahagi, et al.
Publicado: (2021)